1Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
2Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Copyright © 2006 Korean Cancer Association
Patient characteristics
Treatment characteristics
*lymph node, †cyclphosphamide methotrexate, 5-fluorouracil, ‡adriamycin cyclophosphamide, §cyclophosphamide adriamycin, 5-fluorouracil, ∥radiotherapy.
Characteristics according to simulation method
*lymph node, †radiotherapy.
Characteristics of treatment failure
*ipsilateral breast tumor recurrence, †axillary lymph node.
Prognostic factors in the patients with EBC treated by BCT
*disease free survival, †lymph node, ‡radiotherapy.
*lymph node, †cyclphosphamide methotrexate, 5-fluorouracil, ‡adriamycin cyclophosphamide, §cyclophosphamide adriamycin, 5-fluorouracil, ∥radiotherapy.
*lymph node, †radiotherapy.
*ipsilateral breast tumor recurrence, †axillary lymph node.
*disease free survival, †lymph node, ‡radiotherapy.